The board of directors of Johnson & Johnson (NYSE:JNJ) authorised a common stock cash dividend of USD1.01 per share for the first quarter of 2021, the company reported on Monday.
With an ex-dividend date of 22 February 2021, the dividend will be paid on 9 March 2021 to shareholders of record at the close of business on 23 February 2021.
Johnson & Johnson researches and develops, manufactures and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical and Medical Devices.
The company was founded in 1886 and is based in New Brunswick, New Jersey, USA.
Lilly declares Q2 2025 dividend
Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access